| Study name |
Intervention 1 |
Intervention 2 |
Intervention 1: number of participants |
Intervention 2: number of participants |
Presence of other features of decompensation (hepatorenal syndrome, hepatic encephalopathy, or variceal bleeding) |
Alcohol‐related cirrhosis |
Viral‐related cirrhosis |
Other causes for cirrhosis |
Treated for ascites in addition to antibiotics (e.g. albumin or diuretics) |
Follow‐up in months |
Year of recruitment |
| Abd‐Elsalam 2016 |
Cefotaxime |
Ceftriaxone |
Not stated |
Not stated |
Not stated |
Not stated |
Not stated |
Not stated |
Not stated |
0.25 |
2014 |
| Tuncer 2003 |
Cefotaxime |
Ceftriaxone |
18 |
19 |
Includes people with and without other features of decompensation |
Not stated |
Includes people with and without viral‐related cirrhosis |
Includes people with and without other causes of cirrhosis |
Not stated |
0.25 |
Not stated |
| Yim 2017 |
Cefotaxime |
Ceftriaxone |
Not stated |
Not stated |
Not stated |
Not stated |
Not stated |
Not stated |
Not stated |
0.25 |
2007‐2016 |
| Ahmed Ather Ch 2014 |
Ciprofloxacin |
Ceftriaxone |
120 |
120 |
Not stated |
Not stated |
Not stated |
Not stated |
Not stated |
0.25 |
2011 |
| Tuncer 2003 |
Ciprofloxacin |
Ceftriaxone |
16 |
19 |
Includes people with and without other features of decompensation |
Not stated |
Includes people with and without viral‐related cirrhosis |
Includes people with and without other causes of cirrhosis |
Not stated |
0.25 |
Not stated |
| Yim 2017 |
Ciprofloxacin |
Ceftriaxone |
Not stated |
Not stated |
Not stated |
Not stated |
Not stated |
Not stated |
Not stated |
0.25 |
2007‐2016 |
| Figueiredo 1997 |
Cefixime |
Ceftriaxone |
20 |
18 |
Includes people with and without other features of decompensation |
Includes people with and without alcohol‐related cirrhosis |
Not stated |
Not stated |
Not stated |
0.25 |
Not stated |
| Gomez‐Jimenez 1993 |
Cefonicid |
Ceftriaxone |
30 |
30 |
Not stated |
Includes people with and without alcohol‐related cirrhosis |
Not stated |
Includes people with and without other causes of cirrhosis |
Not stated |
0.5 |
1987‐1990 |
| Tuncer 2003 |
Ciprofloxacin |
Cefotaxime |
16 |
18 |
Includes people with and without other features of decompensation |
Not stated |
Includes people with and without viral‐related cirrhosis |
Includes people with and without other causes of cirrhosis |
Not stated |
0.25 |
Not stated |
| Yim 2017 |
Ciprofloxacin |
Cefotaxime |
Not stated |
Not stated |
Not stated |
Not stated |
Not stated |
Not stated |
Not stated |
0.25 |
2007‐2016 |
| Chen 2005 |
Amikacin |
Cefotaxime |
18 |
19 |
Not stated |
Includes people with and without alcohol‐related cirrhosis |
Includes people with and without viral‐related cirrhosis |
Includes people with and without other causes of cirrhosis |
Not stated |
1 |
2000‐2002 |
| Navasa 1996 |
Ofloxacin |
Cefotaxime |
64 |
59 |
Includes people with and without other features of decompensation |
Includes people with and without alcohol‐related cirrhosis |
Not stated |
Includes people with and without other causes of cirrhosis |
Not stated |
0.5 |
1992‐1994 |
| Angeli 2006 |
Ceftazidime |
Ciprofloxacin |
55 |
61 |
Not stated |
Includes people with and without alcohol‐related cirrhosis |
Includes people with and without viral‐related cirrhosis |
Includes people with and without other causes of cirrhosis |
Includes people receiving and not receiving other treatments for ascites |
3 |
Not stated |
| Piano 2016 |
Meropenem plus daptomycin |
Ceftazidime |
15 |
16 |
Not stated |
Includes people with and without alcohol‐related cirrhosis |
Includes people with and without viral‐related cirrhosis |
Includes people with and without other causes of cirrhosis |
Not stated |
3 |
2011 to 2014 |
| Rastegar 1998 |
Pefloxacin |
Ampicillin plus gentamycin |
11 |
9 |
Not stated |
Not stated |
Includes people with and without viral‐related cirrhosis |
Includes people with and without other causes of cirrhosis |
Not stated |
0.25 |
Not stated |
| Jindal 2016 |
Imipenem |
Cefepime |
87 |
88 |
Includes people with and without other features of decompensation |
Includes people with and without alcohol‐related cirrhosis |
Includes people with and without viral‐related cirrhosis |
Includes people with and without other causes of cirrhosis |
Not stated |
3 |
2012‐2014 |
